AzTrials
AzTrials

Achilles Tendon RuptureNCT06252389

Degenerative Achilles Tendon Rupture Repair With Regeneten Augmentation

An observational study of Achilles Tendon Rupture and Achilles Tendinopathy, run by Chinese University of Hong Kong at 1 site in Hong Kong.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Retrospective Case Series to investigate the effect a bovine collagen patch to augmented repair in acute Achilles tendon rupture with pre-existing tendinopathy Read more about this study

Who is it for?
Ages 18 years and older
What is being tested?
Achilles Tendon Repair augmented with Bioinductive Collagen Patch
Type of treatment
Surgery or procedure
How many people
9 participants
Where
1 siteHong Kong
Study dates
1 Feb 2025to Mar 2025
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: All individuals admitted with an acute Achilles tendon rupture

Who may be able to join

  • Pre-operative ultrasound confirmation of tendinopathy

Who cannot join

  • Underwent lower limb intervention with past 3 months
  • Physical or psychological condition impairing ability to consent
  • Physical or psychological condition impairing ability to adhere to rehabilitation protocol
  • allergy to bovine material
  • pregnant individuals

Trial locations and contacts

1 site in 1 country.

Hong Kong1 site
  • Prince of Wales Hospital

    Hong Kong, SAR, HK

Other trials in Hong Kong

About this study

Official title: Treating Achilles Tendon Rupture Complicated by Pre-existing Tendinopathy With Repair Augmented With a Bioinductive Collagen Implant

Retrospective Case Series to investigate the effect a bovine collagen patch to augmented repair in acute Achilles tendon rupture with pre-existing tendinopathy

Read the detailed description

Retrospective Case Series. Investigate the effect a bovine collagen patch to augmented repair in acute Achilles tendon rupture with pre-existing tendinopathy.

Acute Achilles tendon rupture patients all underwent pre-operative ultrasound; those with tendinopathy enrolled into study.

Standard Achilles tendon repair performed; augmented with a bioinductive collagen patch (Regeneten)

Being tested
Achilles Tendon Repair augmented with Bioinductive Collagen Patch
Keywords
Achilles, Regeneten, Tendinopathy
Medical subject headings
Tendinopathy

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Achilles Tendon Repair augmented with Bioinductive Collagen PatchProcedure or surgery

    Standard Achilles Tendon Repair augmented with Bioinductive Collagen Patch. Standard Rehabilitation Protocol.

Study groups in NCT06252389
Study groupRoleWhat they receive
Achilles Regenetenbovine collagen patch to augmented repair in acute Achilles tendon rupture with pre-existing tendinopathy
Receives: Procedure: Achilles Tendon Repair augmented with Bioinductive Collagen Patch

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Foot and Ankle Outcome Score (FAOS)

    Symptoms measured by the patient reported outcome measure FAOS. It is split into 5 sections including: Symptoms, Pain, ADL function, Sporting activity, and Quality of Life.

    Measured: 2 weeks, 6 weeks, 3 months, 6 months

Secondary outcomes (1)
  1. Victoria Institute of Sports Assessment - Achilles (VISA-A)

    Symptoms measured by the Achilles specific patient reported outcome measure VISA-A.

    Measured: 2 weeks, 6 weeks, 3 months, 6 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted9 Feb 2024
  2. Study start1 Feb 2025 (estimated)
  3. Primary completionFeb 2025 (estimated)
  4. Study completionMar 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case only
Time perspective
Retrospective
Enrolment
9 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06252389
Sponsor's protocol ID
AchillesRegeneten
Status last verified
Feb 2024
First submitted
1 Feb 2024
Last updated
9 Feb 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Achilles Tendon Rupture and Achilles Tendinopathy, run by Chinese University of Hong Kong at 1 site in Hong Kong.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 9 Feb 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Hong Kong. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Samuel Ling, MBChB (+852 35052010, samuel.ling@link.cuhk.edu.hk), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Foot and Ankle Outcome Score (FAOS) (time frame: 2 weeks, 6 weeks, 3 months, 6 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Feb 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in